Keyphrases
Clinical Analysis
100%
Randomized Clinical Trial
94%
Meta-analysis
87%
Systematic Meta-analysis
83%
Pediatric Acute Respiratory Distress Syndrome (PARDS)
62%
Serious Adverse Events
56%
Certainty of Evidence
55%
Sepsis
55%
Pediatric Acute Lung Injury Consensus Conference
52%
COVID-19
50%
Antibiotic Regimen
48%
Pediatric
42%
Risk of Bias
42%
Confidence Interval
40%
Placebo
38%
Antibiotics
38%
Ventilator Liberation
37%
Executive Summary
37%
All-cause Mortality
36%
Living Systematic Review
33%
Embase
31%
Risk Ratio
30%
Quinolones
29%
Evaluation Assessment
29%
Assessment Development
29%
Grading of Recommendations
29%
Noninvasive Respiratory Support
27%
Clinical Practice Guidelines
27%
MEDLINE
26%
Secondary Prevention
25%
Network Text
25%
Late-onset Sepsis
25%
Network Meta-analysis
25%
Neonate
24%
Invasive Mechanical Ventilation
22%
High Risk
22%
Neonatal Sepsis
20%
Data Extraction
20%
Quality of Life
18%
Relative Risk
17%
Ovid
16%
Prospero
16%
Beneficial Effects
16%
Myocardial Infarction
16%
Harmful Effects
15%
CINAHL
14%
Cochrane
14%
Chronic Pain
14%
β-lactam Antibiotics
14%
Extubation Readiness Test
14%
Medicine and Dentistry
Pediatrics
100%
Systematic Review
91%
Acute Lung Injury
64%
Acute Respiratory Distress Syndrome
56%
Meta-Analysis
53%
Sepsis
46%
Randomized Clinical Trial
46%
Sequential Analysis
39%
Antibiotics
37%
Assisted Ventilation
33%
Systematic Review with Meta-Analysis
30%
Adverse Event
29%
Neonatal Sepsis
25%
Extubation
24%
Neonate
20%
Artificial Respiration
18%
All Cause Mortality
15%
Placebo
15%
Quality of Life
13%
Clinical Prediction Model
12%
Tramadol
12%
Chronic Pain
12%
Glucocorticoid
12%
Noninvasive Ventilation
12%
Network Meta-Analysis
12%
Chest Tube
12%
COVID-19
12%
Patient-Data
12%
Hospital-Acquired Pneumonia
12%
Surgery
12%
Esophageal Atresia
12%
Quinolone Derivative
12%
Spontaneous Breathing Trial
12%
Randomized Controlled Trial
10%
Disease
9%
Enteric Feeding
7%
Observational Study
7%
Clinical Trial
6%
Intensive Care
5%
Upper Respiratory Tract Obstruction
5%
Muscle Strength
5%
Pediatrics Patient
5%
Respiratory Muscle
5%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Clinical Trial
91%
Adverse Event
82%
Antibiotics
62%
Sepsis
53%
All Cause Mortality
43%
Disease
42%
Placebo
41%
Newborn Sepsis
37%
Quinolone Derivative
30%
Coronavirinae
25%
Antibiotic Agent
24%
Randomized Controlled Trial
20%
Heart Infarction
17%
Chronic Pain
14%
Beta Lactam Antibiotic
14%
Gentamicin
14%
Clinical Trial
13%
Ischemic Heart Disease
13%
Nonoxynol-9
12%
Retinol
12%
Cannabinoid
12%
Model Selection
12%
Heart Failure
12%
Vaccine
12%
Upper Respiratory Tract Obstruction
12%
Molnupiravir
12%
Glucocorticoid
12%
Tramadol
12%
Hospital Mortality
12%
Vaccination Policy
12%
Beta Adrenergic Receptor Blocking Agent
12%
Hospital Acquired Pneumonia
12%
Cardiovascular Mortality
11%
Viral Vector
10%
Necrotizing Enterocolitis
9%
Ritonavir
8%
Nirmatrelvir
8%
Nephrotoxicity
8%
Ototoxicity
8%
Observational Study
8%
Amikacin
7%
Macrolide
6%
Newborn Mortality
6%
Vancomycin
6%
SARS Coronavirus
5%
Acute Heart Infarction
5%
Subunit Vaccine
5%
mRNA Vaccine
5%
Sudden Cardiac Death
5%
